中西医结合治疗冠心病稳定性心绞痛的疗效评价研究(1)
【摘要】目的 本文主要探讨中西医结合治疗冠心病稳定性心绞痛的临床应用价值。方法 选取2015年5月～2018年5月我院收治的冠心病稳定性心绞痛患者42例作为研究对象，将其随机分为观察组和对照组，各21例，对照组患者予常规西医治疗，观察组患者予中西医联合治疗，比较两组患者的治疗效果。结果 观察组患者的心绞痛症状治疗总有效率明显高于对照组患者，治疗3个月的患者SAQ问卷评分总有效率明显高于对照组患者，差异有统计学意义(P<0.05)。结论 本次研究结果表明，中西医联合治疗冠心病稳定性心绞痛患者有助于缓解患者相关心绞痛症状，显著提高患者生活质量，可以进行推广及应用。
【关键词】冠心病稳定性心绞痛;常规西医治疗;中西医联合治疗;治疗效果;复发率
【中图分类号】R541.4 【文献标识码】A 【文章编号】ISSN.2095.6681.2019.29..02
【Abstract】Objective This paper mainly discusses the clinical application value of combined Chinese and western medicine in the treatment of stable angina pectoris of coronary heart disease.Methods From May 2015 to May 2018， 78 patients with coronary heart disease stable angina received treatment in our hospital among whom 42 were taken as subjects for the current research， randomly divided into observation group and control group， with 21 in each. Subjects in the observation group were given combined Chinese and western medicine treatment， while those in the control group were treated with conventional western medication， then effects from the two groups were compared.Results The general effect of the observation group was significantly better than that of the control group， and the general SAQ of subjects in the observation group who received treatment for 3 months showed significantly better results than those of subjects in the control group， and the differences are statistically allowable (P<0.05).Conclusion The results from the study indicate that treatment of stable angina pectoris combining TCM and western medicine is helpful in alleviating symptoms of angina， and improving life quality for patients， and therefore deserves to be popularized.
【Keywords】Coronary heart disease;Stable angina pectoris;Conventional western medicine treatment;Combined treatment of Chinese and western medicine;Therapeutic effect;The recurrence rate.
本次研究主要選取42例冠心病稳定性心绞痛患者作为研究对象，分为两组，分别给予不同的治疗方式，分析中西医结合治疗冠心病稳定性心绞痛的实际临床效果，探讨临床应用价值，现报告如下。
1 资料与方法
1.1 一般资料
选取2015年5月～2018年5月我院收治的冠心病稳定性心绞痛患者42例作为研究对象，将其随机分为观察组和对照组，各21例，均符合慢性稳定性心绞痛临床诊断标准，对照组21例患者给予常规西医药物进行治疗[1]，其中，对照组男10例，女11例，年龄35～80岁，平均年龄(65.97±6.15)岁;观察组给予中西医结合治疗，男11例，女10例，年龄35～80岁，平均年龄(63.62±5.28)岁。两组患者的一般情况(性别、年龄等)比较，差异无统计学意义(P>0.05)。
1.2 研究方法
对照组21例患者给予阿司匹林、血管紧张素转化酶抑制剂、β受体阻滞剂、他汀类药物以及硝酸脂类等药物进行治疗。观察组21例患者给予中西医联合治疗，西医治疗同对照组患者，同时使用血府逐瘀汤合保元汤加减进行治疗，组方：生地15 g、当归15 g、黄芪15 g、人参15 g、赤芍12 g、枳壳12 g、川芎10 g、柴胡10 g、桔梗8 g、牛膝8 g、桃仁8 g、红花5 g、甘草6 g，根据患者的临床症状加减药物，每天一剂，用水煎两次，早晚各服一次。两组患者均在治疗前及治疗3个月时进行西雅图心绞痛量表(SAQ)问卷调查[2]。, 百拇医药(唐亮)
【关键词】冠心病稳定性心绞痛;常规西医治疗;中西医联合治疗;治疗效果;复发率
【中图分类号】R541.4 【文献标识码】A 【文章编号】ISSN.2095.6681.2019.29..02
【Abstract】Objective This paper mainly discusses the clinical application value of combined Chinese and western medicine in the treatment of stable angina pectoris of coronary heart disease.Methods From May 2015 to May 2018， 78 patients with coronary heart disease stable angina received treatment in our hospital among whom 42 were taken as subjects for the current research， randomly divided into observation group and control group， with 21 in each. Subjects in the observation group were given combined Chinese and western medicine treatment， while those in the control group were treated with conventional western medication， then effects from the two groups were compared.Results The general effect of the observation group was significantly better than that of the control group， and the general SAQ of subjects in the observation group who received treatment for 3 months showed significantly better results than those of subjects in the control group， and the differences are statistically allowable (P<0.05).Conclusion The results from the study indicate that treatment of stable angina pectoris combining TCM and western medicine is helpful in alleviating symptoms of angina， and improving life quality for patients， and therefore deserves to be popularized.
【Keywords】Coronary heart disease;Stable angina pectoris;Conventional western medicine treatment;Combined treatment of Chinese and western medicine;Therapeutic effect;The recurrence rate.
本次研究主要選取42例冠心病稳定性心绞痛患者作为研究对象，分为两组，分别给予不同的治疗方式，分析中西医结合治疗冠心病稳定性心绞痛的实际临床效果，探讨临床应用价值，现报告如下。
1 资料与方法
1.1 一般资料
选取2015年5月～2018年5月我院收治的冠心病稳定性心绞痛患者42例作为研究对象，将其随机分为观察组和对照组，各21例，均符合慢性稳定性心绞痛临床诊断标准，对照组21例患者给予常规西医药物进行治疗[1]，其中，对照组男10例，女11例，年龄35～80岁，平均年龄(65.97±6.15)岁;观察组给予中西医结合治疗，男11例，女10例，年龄35～80岁，平均年龄(63.62±5.28)岁。两组患者的一般情况(性别、年龄等)比较，差异无统计学意义(P>0.05)。
1.2 研究方法
对照组21例患者给予阿司匹林、血管紧张素转化酶抑制剂、β受体阻滞剂、他汀类药物以及硝酸脂类等药物进行治疗。观察组21例患者给予中西医联合治疗，西医治疗同对照组患者，同时使用血府逐瘀汤合保元汤加减进行治疗，组方：生地15 g、当归15 g、黄芪15 g、人参15 g、赤芍12 g、枳壳12 g、川芎10 g、柴胡10 g、桔梗8 g、牛膝8 g、桃仁8 g、红花5 g、甘草6 g，根据患者的临床症状加减药物，每天一剂，用水煎两次，早晚各服一次。两组患者均在治疗前及治疗3个月时进行西雅图心绞痛量表(SAQ)问卷调查[2]。, 百拇医药(唐亮)